Grape King Bio (TPE:1707) Other Current Liabilities: NT$203 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1707 Grape King Bio Ltd TPE:1707
79 GF Score
Price NT$91.40
GF Value NT$144.14
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Grape King Bio Other Current Liabilities?

Grape King Bio TPE:1707 -1.40% 79 Other Current Liabilities is NT$203 Mil as of Dec. 2025. GuruFocus rates TPE:1707 with a GF Score™ of 79/100 and a GF Value™ of NT$144.14 (Possible Value Trap). The stock has 5 warning signs investors should review.

Grape King Bio's other current liabilities for the quarter that ended in Dec. 2025 was NT$203 Mil.

Grape King Bio's quarterly other current liabilities increased from Jun. 2025 (NT$176 Mil) to Sep. 2025 (NT$212 Mil) but then declined from Sep. 2025 (NT$212 Mil) to Dec. 2025 (NT$203 Mil).

Grape King Bio's annual other current liabilities increased from Dec. 2023 (NT$179 Mil) to Dec. 2024 (NT$181 Mil) and increased from Dec. 2024 (NT$181 Mil) to Dec. 2025 (NT$203 Mil).

Grape King Bio Other Current Liabilities Related Terms

Grape King Bio Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Grape King Bio's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grape King Bio Other Current Liabilities Chart

Grape King Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 159.94 202.09 178.53 181.41 203.10

Grape King Bio Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 181.41 121.44 176.24 212.00 203.10
TPE:1707
79GF Score
Grape King Bio Ltd TPE:1707
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grape King Bio Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of NT$203 Mil mean?
Grape King Bio (TPE:1707) has a Other Current Liabilities of NT$203 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Grape King Bio.
Is Grape King Bio's Other Current Liabilities too high?
Grape King Bio's current Other Current Liabilities is NT$203 Mil. Overall, Grape King Bio has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Grape King Bio's Other Current Liabilities compare to ZTS and UTHR?
Grape King Bio's Other Current Liabilities of NT$203 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Grape King Bio. Grape King Bio's current Other Current Liabilities is NT$203 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grape King Bio stock overvalued right now?
Based on GuruFocus' analysis, Grape King Bio (TPE:1707) is currently considered Possible Value Trap. The stock's GF Value™ is NT$144.14, compared to a current price of NT$91.40 — trading 36.6% below its estimated fair value. The current Other Current Liabilities is NT$203 Mil. Grape King Bio's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Grape King Bio (TPE:1707), the current Other Current Liabilities is NT$203 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grape King Bio (TPE:1707) Overvalued in 2026?

Based on GuruFocus' analysis, Grape King Bio stock appears to be undervalued. The current stock price of NT$91.40 is trading 36.6% below its estimated GF Value™ of NT$144.14. GuruFocus considers Grape King Bio to be Possible Value Trap.

Key valuation signals for TPE:1707:

  • Other Current Liabilities: NT$203 Mil
  • GF Value™: NT$144.14 vs. price of NT$91.40 (36.6% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the TPE:1707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grape King Bio Business Description

Address Jinling Road, No. 402, Section 2, Pingzhen District, Pingzhen District, Taoyuan, TWN, 324
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food. The company has three segments: MLM (Multi-Level Marketing), which is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, the Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.
79GF Score

Get the complete analysis for TPE:1707

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$91.40
Price
NT$144.14
GF Value